Companies › DMRA

DAMORA THERAPEUTICS INC (DMRA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001800315 · EDGAR filings · Updated 2026-07-28

DAMORA THERAPEUTICS INC (DMRA) has reported institutional ownership of 92.9%, with 65 institutional managers holding positions valued at $1.45B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-28 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — Current report (8-K) filed
• 2026-07-07 — Insider transaction reported (Form 4)
• 2026-06-22 — Notice of proposed sale filed (Form 144)
• 2026-06-17 — Current report (8-K) filed
• 2026-05-15 — SCHEDULE 13G/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, DAMORA THERAPEUTICS INC has 65 institutional holders and institutional ownership of 92.9%.

Insider activity

Insiders reported 17 transactions (0 buys, 6 sells) across 7 reporting insiders, with a net reported value of −$27.2K.

Data flags from SEC filings

Related companies

TANDEM DIABETES CARE INC COM NEW (TNDM) · DEFINIUM THERAPEUTICS F (DFTX) · ATRICURE INC (ATRC) · MONTE ROSA THERAPEUTICS INC (GLUE) · BELITE BIO INC (BLTE) · INTELLIA THERAPEUTICS INC (NTLA)